Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T22:38:46.638Z.
Calculation as of: 2026-10-06T22:38:46.638Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8cea65d131d106392be27e1d05384ba8473c5e5a591a362ec8848616303db7fd
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$198.33M
Free Cash Flow Yield
N/A
TTM Avg
10.09%
3Y Avg
10.09%
5Y Avg
10.09%
Market Cap
$200.96M
Free Cash Flow Yield
N/A
TTM Avg
41.32%
3Y Avg
41.21%
5Y Avg
35.11%
Market Cap
$190.07M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$189.11M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$205.80M
Free Cash Flow Yield
N/A
TTM Avg
0.34%
3Y Avg
0.34%
5Y Avg
0.34%
Market Cap
$207.27M
Free Cash Flow Yield
3.33%
TTM Avg
3.60%
3Y Avg
5.22%
5Y Avg
5.17%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Surrozen, Inc. (SRZN) | $197.18M | N/A | N/A | N/A | N/A |
| Exagen Inc. (XGN)vs › | $197.87M | N/A | N/A | N/A | N/A |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $198.33M | N/A | 10.09% | 10.09% | 10.09% |
| Alector, Inc. (ALEC)vs › | $200.96M | N/A | 41.32% | 41.21% | 35.11% |
| RxSight, Inc. (RXST)vs › | $192.49M | N/A | N/A | N/A | N/A |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $190.07M | N/A | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | N/A | N/A | N/A | N/A |
| Whitehawk Therapeutics Inc (WHWK)vs › | $205.80M | N/A | 0.34% | 0.34% | 0.34% |
| Pro-Dex, Inc. (PDEX)vs › | $207.27M | 3.33% | 3.60% | 5.22% | 5.17% |
| Electra Therapeutics Inc. (ETRA)vs › | $208.31M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
